Incorrect levels of GSK-3ß, a protein linked to Alzheimer's disease, can lead to neural blockages.
Researchers identify a new cell mechanism that connects Alzheimer's disease and cancers.
Researchers discover presenilin, a protein associated with Alzheimer's disease, controls the speed at which materials move through brain cells. Defects in presenilin could lead to neuronal blockages with amyloid plaques, commonly associated with this neurodegenerative disorder.
Researchers implicate presenilin and GSK-3b in the development of Alzheimer's disease.
